Gilead Sciences recently broke ground on a 180,000-square-foot AI-enabled Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus, part of a US$32 billion ...
insights from industrySree VadlamudiVice President, Head of Business Development EU, RoWIktos As part of our SLAS Europe 2022 coverage, we speak to Dr. Sree Vadlamudi, Vice President BD at Iktos, ...
Pharmaceutical Technology on MSN
MSD initiates construction on $3bn Virginia drug manufacturing site
Merck's (MSD) $3bn Virginia facility is part of the big pharma's $70bn US R&D and manufacturing expansion pledge.
For pharmaceutical scientists, the integration of artificial intelligence (AI) and machine learning (ML) into workflows represents a fundamental paradigm shift in how the industry discovers, develops, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback